(S1 (S (NP (NN IL-4)) (VP (VBZ Inhibits) (NP (JJ TGF-beta-Mediated) (NN iTreg) (NN Commitment)))))
(S1 (S (S (NP (JJ CFSE-labeled) (JJ CD4+CD45RA+) (NNS cells)) (VP (VBD were) (VP (VBN activated) (PP (IN with) (NP (NP (JJ plate-bound) (NN anti-CD3/CD28)) (, ,) (NP (NN TGF-beta)) (, ,) (CC and) (NP (NN IL-4))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated)))))) (. .)))
(S1 (S (S (S (PP (IN After) (NP (CD 5) (NN d))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))))))) (CC and) (S (NP (NP (NNS results)) (PP (IN of) (NP (CD six) (JJ independent) (NNS experiments)))) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (NN bar) (NN graph)) (PRN (IN below) (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (JJ Statistical) (NN significance)) (PRN (-LRB- -LRB-) (NP (NP (NN one-way) (NN Anova)) (, ,) (NP (NN Newman-Keuls))) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN indicated) (PP (IN by) (NP (NP (NNS asterisks)) (PRN (-LRB- -LRB-) (NP (NP (NN **p) (NN <)) (ADJP (JJ =) (NP (CD 0.01)))) (, ,) (S (NP (NN ***p) (CD <)) (VP (JJ =) (NP (CD 0.001)))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (JJ Kinetic) (NN analysis)) (PP (IN of) (NP (NP (JJ intracellular) (NN GATA3)) (CC and) (NP (NN FOXP3) (NN staining))))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NN panel) (NN C))) (PP (VBG following) (NP (NP (NN exposure)) (PP (IN of) (NP (JJ CD4+CD45RA+) (NN T) (NNS cells))) (PP (TO to) (NP (NP (NN anti-CD3/28)) (, ,) (NP (NN IL-4)) (CC and) (NP (NN TGF-beta))))))))) (. .)))
(S1 (S (S (NP (NNS Data)) (VP (VBP are) (ADJP (JJ representative) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))))) (. .)))
